Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16513
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMateu, Laura-
dc.contributor.authorIzquierdo, Laura-
dc.contributor.authorFranco, Agustín-
dc.contributor.authorCosta, Meritxell-
dc.contributor.authorLawrentschuk, Nathan-
dc.contributor.authorAlcaraz, Antonio-
dc.date2016-12-06-
dc.date.accessioned2017-01-15T23:05:38Z-
dc.date.available2017-01-15T23:05:38Z-
dc.date.issued2017-07-
dc.identifier.citationInternational Urogynecology Journal 2017; 28(7): 1027-1031en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/16513-
dc.description.abstractINTRODUCTION AND HYPOTHESIS: Bladder pain syndrome (BPS) is a chronic condition with severe implications in the patient's quality of life with no definitive treatment. Our objective was to assess pain relief after triamcinolone injection in patients with BPS with Hunner's ulcers (HU). METHODS: Retrospective study of 20 consecutive patients with BPS treated at the Hospital Clinic of Barcelona with triamcinolone injection with flexible cystoscope between 2015 and 2016. Pain was assessed according to the visual analog scale (VAS) (0-10) before and after treatment. Outcomes were compared using Student's t test for paired samples. RESULTS: Twenty-seven procedures were performed in 20 patients, who were followed up for a median of 7 months (range 1-15). Median age was 75 years (52-86), and median time from diagnosis to treatment was 4.5 years (1-7). Fifteen (75 %) patients had received treatment with corticoid injection for BPS before entering the study. Pre- and postreatment VAS was 8 and 2.5 (p < 0.001), respectively. Pre -and postreatment VAS in those with muscular pain was 8 and 5 (p = 0.012), respectively and in those without muscular pain was 8 and 2 (p < 0.001), respectively. Three (15 %) patients required retreatment due to nonresponse and 5 (25 %) patients for pain recurrence after 4 months (3.5-8). Four of them (50 %) were performed with triamcinolone injection again. Seven of ten patients (70 %) followed for ≥8 months required at least one retreatment. CONCLUSION: Triamcinolone injection for HU in patients with BPS is associated with significant pain reduction. However, most patients will require retreatment.en_US
dc.subjectBladder pain syndromeen_US
dc.subjectHunner ulceren_US
dc.subjectTriamcinoloneen_US
dc.titlePain relief after triamcinolone infiltration in patients with bladder pain syndrome with Hunner's ulcersen_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleInternational Urogynecology Journalen_US
dc.identifier.affiliationDepartment and Laboratory of Urology of Hospital Clinic, Barcelona, Spainen_US
dc.identifier.affiliationDepartment of Urology of Hospital Plató, Barcelona, Spainen_US
dc.identifier.affiliationDepartment of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen_US
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/27924374en_US
dc.identifier.doi10.1007/s00192-016-3213-3en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0001-8553-5618en_US
dc.type.austinJournal Articleen_US
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Nov 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.